9700_w19_qp_21
A paper of Biology, 9700
Questions:
6
Year:
2019
Paper:
2
Variant:
1

Login to start this paper & get access to powerful tools

1
2
is a transmission electron micrograph showing the bacterial pathogen that causes tuberculosis (TB). Name the pathogen shown in that causes TB. The World Health Organization (WHO) introduced a strategy in 2015 to end the global TB epidemic. An important part of the strategy is to: • identify people at risk of becoming infected with TB • use methods to prevent transmission of TB. The BCG vaccination is one method of prevention recommended for use in countries where TB is common. The BCG vaccine contains a non-pathogenic, living form of the microorganism that causes TB. Complete Table 2.1 by using a tick (✓) to identify the type of immunity that develops in a person who has been given the BCG vaccination. Table 2.1 artificial active immunity artificial passive immunity natural active immunity natural passive immunity Rifampicin is one of the antibiotics used to treat TB. Rifampicin inhibits RNA polymerase in bacterial cells by binding to a site other than the active site. This prevents polypeptide synthesis. Suggest and explain how rifampicin prevents polypeptide synthesis in bacterial cells. Some bacteria have developed resistance to rifampicin. However, they are still susceptible to the other antibiotics that can be used to treat TB. Multi-drug resistant bacteria have developed resistance to at least two drugs, including rifampicin. WHO collects data from all countries on the number of cases of TB caused by rifampicin-resistant bacteria (RR-TB) and multi-drug resistant bacteria (MDR-TB). shows the reported number of cases of TB between 2009 and 2013. 160 000 120 000 80 000 40 000 year reported number of cases of RR-TB and MDR-TB Describe the trend shown by the data in . Explain how resistance to drugs such as rifampicin develops.
3
4
5
6